A mass spectrometric analysis of 4-hydroxy-2-(E)-nonenal modification of cytochrome c

Journal of Mass Spectrometry

Volumn 46, Issue 3, 2011, Pages 290-297

  Tang, Xiaoxia ^a   Sayre, Lawrence M ^a   Tochtrop, Gregory P ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

4 hydroxy 2 nonenal (4 HNE); Lipid oxidation; Protein modification; Reactive oxygen species

Indexed keywords

4-HYDROXY-2-NONENAL; CYTOCHROME C; IN-VITRO; ISOTOPE LABELING; LC-ESI-MS/MS; LIPID OXIDATION; LIPID PEROXIDATION; MALDI-TOF MASS SPECTROMETRY; MASS SPECTROMETRIC ANALYSIS; MICHAEL ADDITIONS; MITOCHONDRIAL MEMBRANES; PROTEIN MODIFICATION; PROTEOLYTIC PEPTIDES; REACTIVE OXYGEN SPECIES; SIDE CHAINS;

ADDITION REACTIONS; CELL MEMBRANES; ISOTOPES; LINOLEIC ACID; MASS SPECTROMETRY; MITOCHONDRIA; OXYGEN; PROTEINS;

OXIDATION;

4 HYDROXYNONENAL; CYTOCHROME C; REACTIVE OXYGEN METABOLITE;

ARTICLE; CHEMICAL MODIFICATION; ISOTOPE LABELING; LIPID PEROXIDATION; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DENATURATION;

ALDEHYDES; AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, LIQUID; CYTOCHROMES C; HORSES; PEPTIDE FRAGMENTS; PROTEIN STABILITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 79952550111     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1890     Document Type: Article

References (72)

1. E. Schauenstein, H. Esterbauer, G. Jaag, M. Taufer. Action of aldehydes on healthy and malignant cells. I. 4-hydroxy-2-transoctenal, a new fatty aldehyde. Monatsh. Chem. 1964, 95, 180.
2. G. Poli, R. J. Schaur. 4-hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life. 2000, 50, 315.
3. N. Zarkovic. 4-hydroxynonenal as a bioactive marker of pathophysiological processes. Mol. Aspects Med. 2003, 24, 281.
4. A. Bierhaus, P. I. Moreira, A. I. Duarte, M. S. Santos, A. C. Rego, C. R. Oliveira. An integrative view of the role of oxidative stress, mitochondria and insulin in alzheimer's disease. J. Alzheimer's Dis. 2009, 16, 741.
5. M. E. Harper, L. Bevilacqua, K. Hagopian, R. Weindruch, J. J. Ramsey. Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiol. Scand. 2004, 182, 321.
6. W. Jassem, S. V. Fuggle, M. Rela, D. D. H. Koo, N.D.Heaton. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002, 73, 493.
7. Z. Makazan, H. K. Saini, N. S. Dhalla. Role of oxidative stress in alterations ofmitochondrial function in ischemic-reperfused hearts. Am. J. Physiol. 2007, 292, H1986.
8. P. I. Moreira, M. S. Santos, C. R. Oliveira.Alzheimer's disease:Alesson from mitochondrial dysfunction. Antioxid. Redox Signaling. 2007, 9, 1621.
9. S. Orrenius, V. Gogvadze, B. Zhivotovsky. Mitochondrial oxidative stress: Implications for cell death. Annu. Rev. Pharmacol. Toxicol. 2007, 47, 143.
10. L. Piconi, L. Quagliaro, A. Ceriello. Oxidative stress in diabetes. Clin. Chem. Lab. Med. 2003, 41, 1144.
11. S. Sadhukhan, Y. Han, G.-F. Zhang, H. Brunengraber, G. P. Tochtrop. Using isotopic tools to dissect and quantitate parallel metabolic pathways. J. Am. Chem. Soc. 2010, 132, 6309.
12. G.-F. Zhang, R. S. Kombu, T. Kasumov, Y. Han, S. Sadhukhan, J. Zhang, L. M. Sayre, D. Ray, K. M. Gibson, V. A. Anderson, G. P. Tochtrop, H. Brunengraber. Catabolismof 4-hydroxyacids and 4-hydroxynonenal via 4-hydroxy-4-phosphoacyl- coas. J. Biol. Chem. 2009, 284, 33521.
13. H. Esterbauer, R. J. Schaur, H. Zollner. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol.Med. 1991, 11, 81.
14. K. Uchida. 4-hydroxy-2-nonenal: A product and mediator of oxidative stress. Prog. Lipid Res. 2003, 42, 318.
15. J. Chen, G. I. Henderson, G. L. Freeman. Role of 4-hydroxynonenal in modification of cytochrome c oxidase in ischemia/reperfused rat heart. J.Mol. Cell. Cardiol. 2001, 33, 1919.
16. J. Chen, S. Schenker, T. A. Frosto, G. I. Henderson. Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (hne). Role of hne adduct formation with the enzyme subunits. Bioch. Biophys. Acta. 1998, 1380, 336.
17. J. A. Cohn, L. Tsai, B. Friguet, L. I. Szweda. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: Immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochem. Biophys. 1996, 328, 158.
18. R. L. Haynes, B. Brune, A. J. Townsend. Apoptosis in raw 264.7 cells exposed to 4-hydroxy-2-nonenal: Dependence on cytochrome c release but not p53 accumulation. Free Radical Biol. Med. 2001, 30, 884.
19. K. M. Humphries, Y. Yoo, L. I. Szweda. Inhibition of nadh-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 1998, 37, 552.
20. P. Kaplan, Z. Tatarkova, P. Racay, J. Lehotsky, M. Pavlikova, D. Dobrota. Oxidative modifications of cardiac mitochondria and inhibition of cytochrome c oxidase activity by 4-hydroxynonenal. Redox Report 2007, 12, 211.
21. J. N. Keller, K. B. Hanni, W. R. Markesbery. 4-hydroxynonenal increases neuronal susceptibility to oxidative stress. J. Neurosci. Res. 1999, 58, 823.
22. B. S. Kristal, B. K. Park, B. P. Yu. 4-hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 1996, 271, 6033.
23. O. Kutuk, H. Basaga. Apoptosis signalling by 4-hydroxynonenal: A role for jnk-c-jun/ap-1 pathway. Redox Rep. 2007, 12, 30.
24. J. C. LaManna, N. L. Neubauer, J. C. Chavez. Formation of 4-hydroxy-2-nonenal-modified proteins in the rat brain following transient global ischemia induced by cardiac arrest and resuscitation. Maturation Phenom. Cereb. Ischemia IV, Int. Workshop, 4th 2001, 223.
25. O.M. Lashin, P. A. Szweda, L. I. Szweda, A.M. P. Romani. Decreased complex ii respiration and hne-modified sdh subunit in diabetic heart. Free Radical Biol. Med. 2006, 40, 886.
26. J. Y. Lee, G. Y. Jung, H. J. Heo, M. R. Yun, J. Y. Park, S. S. Bae, K. W. Hong, W. S. Lee, C. D. Kim. 4-hydroxynonenal induces vascular smoothmuscle cell apoptosis throughmitochondrial generation of reactive oxygen species. Toxicol. Lett. 2006, 166, 212.
27. D. T. Lucas, L. I. Szweda. Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 510.
28. I. Nakashima, W. Liu, A. A. Akhand, K. Takeda, Y. Kawamoto, M. Kato, H. Suzuki. 4-hydroxynonenal triggers multistep signal transduction cascades for suppression of cellular functions. Mol. Aspects Med. 2003, 24, 231.
29. V. B. Patel, C. H. Spencer, T. A. Young, M. O. Lively, C. C. Cunningham. Effects of 4-hydroxynonenal on mitochondrial 3-hydroxy-3-methylglutaryl (hmg-coa) synthase. Free Radical Biol. Med. 2007, 43, 1499.
30. M. J. Picklo, V. Amarnath, J. O. McIntyre, D. G. Graham, T. J. Montine. 4-hydroxy-2(e)-nonenal inhibits cns mitochondrial respiration at multiple sites. J.Neurochem. 1999, 72, 1617.
31. H. Raza, A. John. 4-hydroxynonenal induces mitochondrial oxidative stress, apoptosis and expression of glutathione s-transferase a4-4 and cytochrome p450 2e1 in pc12 cells. Toxicol. Appl. Pharmacol. 2006, 216, 309.
32. H. Raza, A. John, E. M. Brown, S. Benedict, A. Kambal. Alterations in mitochondrial respiratory functions, redox metabolism and apoptosis by oxidant 4-hydroxynonenal and antioxidants curcumin and melatonin in pc12 cells. Toxicol. Appl. Pharmacol. 2008, 226, 161.
33. P. Sompol, W. Ittarat, J. Tangpong, Y. Chen, I. Doubinskaia, I. Batinic-Haberle, H. M. Abdul, D. A. Butterfield, D. K. St. Clair. A neuronal model of alzheimer's disease: An insight into the mechanisms of oxidative stress-mediatedmitochondrial injury. Neuroscience.2008, 153, 120.
34. S. M. Stevens, Jr., N. Rauniyar, L. Prokai. Rapid characterization of covalent modifications to rat brain mitochondrial proteins after ex vivo exposure to 4-hydroxy-2-nonenal by liquid chromatography-tandem mass spectrometry using data-dependent and neutral loss-driven ms3 acquisition. J. Mass Spectrom. 2007, 42, 1599.
35. A. M. Winger, N. L. Taylor, J. L. Heazlewood, D. A. Day, A. H. Millar. The cytotoxic lipid peroxidation product 4-hydroxy-2-nonenal covalently modifies a selective range of proteins linked to respiratory function in plant mitochondria. J.Biol. Chem. 2007, 282, 37436.
36. C. Ji, V. Amarnath, J. A. Pietenpol, L. J. Marnett. 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem. Res. Toxicol. 2001, 14, 1090.
37. F. R. Salemme. Structure and function of cytochromes c. Annu. Rev. Biochem. 1977, 46, 299.
38. F. R. Salemme, J. Kraut, M. D. Kamen. Structural bases for functionin cytochromes c. Interpretationof comparative x-rayandbiochemical data. J. Biol. Chem. 1973, 248, 7701.
39. D. Lin, H.-g. Lee, Q. Liu, G. Perry, M. A. Smith, L. M. Sayre. 4-oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 2005, 18, 1219.
40. D. V. Nadkarni, L. M. Sayre. Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 1995, 8, 284.
41. G. Xu, Y. Liu, L. M. Sayre. Independent synthesis, solution behavior, and studies on the mechanism of formation of a primary amine-derived fluorophore representing cross-linking of proteins by (e)-4-hydroxy-2-nonenal. J. Org. Chem. 1999, 64, 5732.
42. M. Ethen Cheryl, C. Reilly, X. Feng, W. Olsen Timothy, A. Ferrington Deborah. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest. Ophthalmol. Vis. Sci. 2007, 48, 3469.
43. M.Orioli, G. Aldini, M. C. Benfatto, R. M. Facino, M. Carini. Hne michael adducts to histidine and histidine-containing peptides as biomarkers of lipid-derived carbonyl stress in urines: Lc-ms/ms profiling in zucker obese rats. Anal. Chem. 2007, 79, 9174.
44. J. R. Requena, M.-X. Fu, M. U. Ahmed, A. J. Jenkins, T. J. Lyons, S. R. Thorpe. Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions. Nephrol., Dial., Transplant. 1996, 11, 48.
45. J. N. Riggins, D. C. Liebler. Identification of lipid oxidation-induced adducts to human serum albumin: Potential markers of oxidative stress. Abstracts of Papers, 228th ACS National Meeting, Philadelphia, PA, United States, August 22-26, 2004.
46. K. Uchida. Protein-bound 4-hydroxy-2-nonenal as a marker of oxidative stress. J. Clin. Biochem. Nutr. 2005, 36, 1.
47. M. Hashimoto, T. Sibata, H.Wasada, S. Toyokuni, K. Uchida. Structural basis of protein-bound endogenous aldehydes. J. Biol. Chem. 2003, 278, 5044.
48. K. Uchida, K. Itakura, S. Kawakishi, H. Hiai, S. Toyokuni, E. R. Stadtman. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 1995, 324, 241.
49. K. Uchida, L. I. Szweda, H. Z. Chae, E. R. Stadtman. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc. Natl. Acad. Sci. U. S. A. 1993, 90, 8742.
50. G. Aldini, L. Gamberoni, M. Orioli, G. Beretta, L. Regazzoni, R. M. Facino, M. Carini. Mass spectrometric characterization of covalent modification of human serum albumin by 4-hydroxytrans-2-nonenal. J.Mass Spectrom. 2006, 41, 1149.
51. G. Aldini, M. Orioli, M. Carini. Alpha, beta -unsaturated aldehydes adducts to actin and albumin as potential biomarkers of carbonylation damage. Redox Rep. 2007, 12, 20.
52. S. P. Annangudi, Y. Deng, X. Gu, W. Zhang, J. W. Crabb, R. G. Salomon. Low-density lipoprotein has an enormous capacity to bind (e)-4-hydroxynon-2-enal (hne): Detection and characterization of lysyl and histidyl adducts containing multiple molecules of hne. Chem. Res. Toxicol. 2008, 21, 1384.
53. A. Bennaars-Eiden, L. Higgins, A. V. Hertzel, R. J. Kapphahn, D. A. Ferrington, D. A. Bernlohr. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. J. Biol. Chem. 2002, 277, 50693.
54. M. S. Bolgar, S. J. Gaskell. Determination of the sites of 4-hydroxy-2-nonenal adduction to protein by electrospray tandem mass spectrometry. Anal. Chem. 1996, 68, 2325.
55. D. L. Carbone, J. A. Doorn, Z. Kiebler, B. R. Ickes, D. R. Petersen. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease. J. Pharmacol. Exp. Ther. 2005, 315, 8.
56. M. Carini, G. Aldini, R. M. Facino. Mass spectrometry for detection of 4-hydroxy-trans-2-nonenal (hne) adducts with peptides and proteins. Mass Spectrom. Rev. 2004, 23, 281.
57. S. G. Codreanu, B. Zhang, S. M. Sobecki, D. D. Billheimer, D. C. Liebler. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol. Cell. Proteomics. 2009, 8, 670.
58. L. Farout, J. Mary, J. Vinh, L. I. Szweda, B. Friguet. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20s proteasome subtypes. Arch. Biochem. Biophys. 2006, 453, 135.
59. F. Fenaille, P. A. Guy, J.-C. Tabet. Study of protein modification by 4-hydroxy-2-nonenal and other short chain aldehydes analyzed by electrospray ionization tandem mass spectrometry. J.Am. Soc.Mass Spectrom. 2003, 14, 215.
60. F. Fenaille, J.-C. Tabet, P. A. Guy. Identification of 4-hydroxy-2-nonenal-modified peptides within unfractionated digests using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal. Chem. 2004, 76, 867.
61. S. N. A. Hussain, G. Matar, E. Barreiro, M. Florian, M. Divangahi, T. Vassilakopoulos. Modifications of proteins by 4-hydroxy-2-nonenal in the ventilatory muscles of rats. Am. J. Physiol. 2006, 290, L996.
62. T. Ishii, E. Tatsuda, S. Kumazawa, T. Nakayama, K. Uchida. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: Identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase. Biochemistry. 2003, 42, 3474.
63. L. Isom Amanda, S. Barnes, L. Wilson, M. Kirk, L. Coward, V. Darley-Usmar. Modification of cytochrome c by 4-hydroxy- 2-nonenal: Evidence for histidine, lysine, and arginine-aldehyde adducts. J Am SocMass Spectrom. 2004, 15, 1136.
64. R. J. Kapphahn, B. M. Giwa, K. M. Berg, H. Roehrich, X. Feng, T. W. Olsen, D. A. Ferrington. Retinal proteins modified by 4-hydroxynonenal: Identification of molecular targets. Exp. Eye Res. 2006, 83, 165.
65. Z. Liu, P. E. Minkler, L. M. Sayre. Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(e)-nonenal and 4-oxo-2-(e)-nonenal. Chem. Res. Toxicol. 2003, 16, 901.
66. F. Magni, C. Galbusera, L. Tremolada, C. Ferrarese, M. G. Kienle. Characterisation of adducts of the lipid peroxidation product 4-hydroxy-2-nonenal and amyloid beta -peptides by liquid chromatography/ electrospray ionizationmass spectrometry. Rapid Commun.Mass Spectrom. 2002, 16, 1485.
67. A. Musatov, C. A. Carroll, Y.-C. Liu, G. I. Henderson, S. T. Weintraub, N. C. Robinson. Identification of bovine heart cytochrome c oxidase subunits modified by the lipid peroxidation product 4-hydroxy-2-nonenal. Biochemistry. 2002, 41, 8212.
68. M. Orioli, G. Aldini, G. Beretta, R. M. Facino, M. Carini. Lc-esi-ms/ms determination of 4-hydroxy-trans-2-nonenal michael adducts with cysteine and histidine-containing peptides as early markers of oxidative stress in excitable tissues. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2005, 827, 109.
69. N. Rauniyar, S. M. Stevens, Jr., K. Prokai-Tatrai, L. Prokai. Characterization of 4-hydroxy-2-nonenal-modified peptides by liquid chromatography-tandem mass spectrometry using data-dependent acquisition: Neutral loss-driven ms3 versus neutral loss-driven electron capture dissociation. Anal. Chem. 2009, 81, 782.
70. W.-H.Zhang, J.Liu, G.Xu, Q.Yuan, L.M.Sayre. Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 2003, 16, 512.
71. R. F. Borch, M. D. Bernstein, H. D. Durst. Cyanohydridoborate anion as a selective reducing agent. J. Amer. Chem. Soc. 1971, 93, 2897.
72. D. B. Kinghorn, L. Adamowicz. Electron affinity of hydrogen, deuterium, and tritium:Anonadiabatic variational calculation using explicitly correlated gaussian basis functions. J. Chem. Phys. 1997, 106, 4589.